Metabolic alterations in patients with hormonally active pheochromocytoma/paraganglioma (PPGL) have been described early on in the literature. The initial findings were related to disturbed glucose homeostasis and lipolysis activation, as well as elevated metabolic rates in affected patients. Similarly, from early autopsy reports, the presence of brown adipose tissue had been noted in PPGL patients. In more recent years, changes in body weight, fat mass and distribution have been analyzed in more detail in addition to activity of brown adipose tissue based on functional imaging techniques. Over the last decades, several larger case series and cohort studies have contributed towards the elucidation of possible mechanism contributing to these...
Pheochromocytomas and paragangliomas (PPGLs) can be localized by F-18-FDG PET. The uptake is particu...
Pheochromocytomas and paragangliomas (PPGLs) can be localized by (18)F-FDG PET. The uptake is partic...
Copyright © 2013 Gianluca Iacobellis et al. This is an open access article distributed under the Cre...
Metabolic alterations in patients with hormonally active pheochromocytoma/paraganglioma (PPGL) have ...
Pheochromocytoma and functional paraganglioma (PPGL) are rare neuroendocrine tumors characterized by...
CONTEXT: Patients with pheochromocytomas and paragangliomas (PGLs) may have brown adipose tissue (BA...
Context: Patients with pheochromocytomas and paragangliomas (PGLs) may have brown adipose tissue (BA...
Fibroblast growth factor 21 (FGF21) is a hepatokine with beneficial effects on metabolism. Our aim w...
PURPOSE Pheochromocytomas and Paragangliomas (PPGL) result in chronic catecholamine excess and se...
PURPOSE: Pheochromocytomas and Paragangliomas (PPGL) result in chronic catecholamine excess and seri...
The presence of brown adipose tissue (BAT) in humans is unclear. Pheochromocytomas (PHEO) are rare t...
Objective: Within the past decade, important genetic drivers of pheochrom ocytoma and paraganglioma ...
OBJECTIVE: Within the past decade, important genetic drivers of pheochromocytoma and paraganglioma (...
Pheochromocytomas and paragangliomas (PPGLs) can be localized by F-18-FDG PET. The uptake is particu...
Pheochromocytomas and paragangliomas (PPGLs) can be localized by (18)F-FDG PET. The uptake is partic...
Copyright © 2013 Gianluca Iacobellis et al. This is an open access article distributed under the Cre...
Metabolic alterations in patients with hormonally active pheochromocytoma/paraganglioma (PPGL) have ...
Pheochromocytoma and functional paraganglioma (PPGL) are rare neuroendocrine tumors characterized by...
CONTEXT: Patients with pheochromocytomas and paragangliomas (PGLs) may have brown adipose tissue (BA...
Context: Patients with pheochromocytomas and paragangliomas (PGLs) may have brown adipose tissue (BA...
Fibroblast growth factor 21 (FGF21) is a hepatokine with beneficial effects on metabolism. Our aim w...
PURPOSE Pheochromocytomas and Paragangliomas (PPGL) result in chronic catecholamine excess and se...
PURPOSE: Pheochromocytomas and Paragangliomas (PPGL) result in chronic catecholamine excess and seri...
The presence of brown adipose tissue (BAT) in humans is unclear. Pheochromocytomas (PHEO) are rare t...
Objective: Within the past decade, important genetic drivers of pheochrom ocytoma and paraganglioma ...
OBJECTIVE: Within the past decade, important genetic drivers of pheochromocytoma and paraganglioma (...
Pheochromocytomas and paragangliomas (PPGLs) can be localized by F-18-FDG PET. The uptake is particu...
Pheochromocytomas and paragangliomas (PPGLs) can be localized by (18)F-FDG PET. The uptake is partic...
Copyright © 2013 Gianluca Iacobellis et al. This is an open access article distributed under the Cre...